Downloads

  1. Are You In Control Of Your Protein Galactosylation Profile? 5/12/2025

    Enhance therapeutic success by optimizing N-glycan profiles with titratable formulations tailored to meet your bioproduction needs.

  2. ADCs Unleashed: Navigating Development Hurdles In Targeted Cancer Therapy 5/12/2025

    Despite their potential to revolutionize treatment paradigms, antibody-drug conjugates (ADCs) face challenges that companies must tackle for successful development.

  3. PSC Perfusion Guidance Using Vertical-Wheel Bioreactors 5/9/2025

    Unlock the potential of perfusion for pluripotent stem cell cultures. Explore key insights into achieving improved consistency and quality in your medium exchange protocols, leading to better outcomes.

  4. Pull Your Fill/Finish Line Closer 5/9/2025

    By partnering with us, you gain access to our unique, interconnected network, purpose-built to overcome the breakpoints common in traditional manufacturing models.

  5. A Case For Paying Allogeneic Cell Therapy Product Donors 5/9/2025

    The debate over whether to pay donors for cell therapy starting materials comes down to four areas of disagreement: altruism, availability, ethics, and safety.

  6. The Role Of Peptones In Boosting Monoclonal Antibody Production 5/9/2025

    Peptones have become a key tool in CHO cell bioprocessing, enhancing monoclonal antibody yield and quality.

  7. Equip Your Team With Expert Pharmaceutical Training 5/9/2025

    Invest in your workforce's future. Techceuticals delivers specialized pharmaceutical manufacturing training, ensuring your team masters solid dose processes, boosts efficiency, and meets crucial standards.

  8. April 2025 — CDMO Opportunities And Threats Report 5/8/2025

    Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers. The report identifies CDMOs that might be impacted by key events affecting their clients, including company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections.

  9. Incorporating AI Tools Into Downstream Process Optimization 5/8/2025

    Data-driven, hybrid modeling complements mechanistic thinking by reducing computational load for faster decision-making when time is a critical consideration.

  10. A Road Map For PAT Monitoring And Control 5/8/2025

    Process analytic technology monitoring and control is rapidly progressing. BioPhorum shares new best practices on how to move from concept through life cycle management and/or regulatory approval of the PAT application.